Evidence map›Paper›PMID 31304392›Full record

ArticleNPJ digital medicine2019

Smartphone-based migraine behavioral therapy: a single-arm study with assessment of mental health predictors.

Mia T Minen, Samrachana Adhikari, Elizabeth K Seng, Thomas Berk, Sarah Jinich, Scott W Powers, Richard B Lipton

Open access · goldAbstract read
In one paragraph

Article in NPJ digital medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Review
  17. Computerized migraine diagnostic tools: a systematic review.Therapeutic advances in chronic disease · 2022
    Article
  18. Article
  19. 21st century headache: mapping new territory.The journal of headache and pain · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mia T Minen1NYU Langone Health, New York, NY USA.
Samrachana Adhikari1NYU Langone Health, New York, NY USA.
Elizabeth K Seng2Albert Einstein College of Medicine, New York, NY USA.
Thomas Berk1NYU Langone Health, New York, NY USA.
Sarah Jinich3Columbia University, New York, NY USA.
Scott W Powers4Cincinnati Children's Hospital, Cincinnati, OH USA.
Richard B Lipton2Albert Einstein College of Medicine, New York, NY USA.
NYU Langone Health · USAlbert Einstein College of Medicine · USCincinnati Children's Hospital Medical Center · USColumbia University · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Clinical Decision Support for Patient Migraine ManagementK23NS096107 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SENG-TAMACCIO, ELIZABETH K · 2016 to 2020
$965k
Progressive Muscle Relaxation for Chronic Pain in an Acute Care SettingK23AT009706 · NCCIH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MINEN, MIA · 2018 to 2022
$923k
NCATS NIH HHS UL1 TR001445NCCIH NIH HHS K23 AT009706NINDS NIH HHS K23 NS096107
6 · The paper itself

Abstract

Progressive muscle relaxation (PMR) is an under-utilized Level A evidence-based treatment for migraine prevention. We studied the feasibility and acceptability of smartphone application (app)-based PMR for migraine in a neurology setting, explored whether app-based PMR might reduce headache (HA) days, and examined potential predictors of app and/or PMR use. In this single-arm pilot study, adults with ICHD3 migraine, 4+ HA days/month, a smartphone, and no prior behavioral migraine therapy in the past year were asked to complete a daily HA diary and do PMR for 20 min/day for 90 days. Outcomes were: adherence to PMR (no. and duration of audio plays) and frequency of diary use. Predictors in the models were baseline demographics, HA-specific variables, baseline PROMIS (patient-reported outcomes measurement information system) depression and anxiety scores, presence of overlapping pain conditions studied and app satisfaction scores at time of enrollment. Fifty-one patients enrolled (94% female). Mean age was 39 ± 13 years. The majority (63%) had severe migraine disability at baseline (MIDAS). PMR was played 22 ± 21 days on average. Mean/session duration was 11 ± 7 min. About half (47%) of uses were 1+ time/week and 35% of uses were 2+ times/week. There was a decline in use/week. On average, high users (PMR 2+ days/week in the first month) had 4 fewer days of reported HAs in month 2 vs. month 1, whereas low PMR users (PMR < 2 days/week in the first month) had only 2 fewer HA days in month 2. PROMIS depression score was negatively associated with the log odds of using the diary at least once (vs. no activity) in a week (OR = 0.70, 95% CI = [0.55, 0.85]) and of doing the PMR at least once in a week (OR = 0.77, 95% CI = [0.68, 0.91]). PROMIS anxiety was positively associated with using the diary at least once every week (OR = 1.33, 95% CI = [1.09, 1.73]) and with doing the PMR at least once every week (OR = 1.14 [95% CI = [1.02, 1.31]). In conclusion, about half of participants used smartphone-based PMR intervention based upon a brief, initial introduction to the app. App use was associated with reduction in HA days. Higher depression scores were negatively associated with diary and PMR use, whereas higher anxiety scores were positively associated.

Indexed as

Medical researchNeurology

Identifiers

PMID31304392
PMCPMC6550263
OpenAlexW2948510341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.